OUR BUSINESS
Our Company was incorporated on October 26, 2018 We are a global company headquartered in India, specializing in turnkey engineering solutions for pharmaceuticals, biotech and healthcare companies.
- Start-to-Finish
- Solutions for Air
- Solutions for Water
- Solutions for Process
We provide extensive technical expertise and infrastructure to deliver comprehensive solutions for establishing aseptic manufacturing facilities, encompassing everything from design to certification.
Our footprint spans more than 62 countries globally and across regions including but not limited to, Middle East, Africa, Asia, Europe, Latin America, North America etc.
Our Company has presence across some of the key emerging economies like Bangladesh, Egypt, Ethiopia, India, Kenya, Kingdom of Saudi Arabia, Morocco, Nicaragua, Nigeria, South Africa, Turkey and Tanzania .
We build pharmaceutical, biotech and healthcare capabilities by offering comprehensive start to finish solutions encompassing designing, engineering, procurement, installation and testing of select pharmaceutical equipment for a wide range of customers.
The COVID-19 pandemic highlighted the importance of having proper healthcare infrastructure and local manufacturing capabilities of necessary drugs and vaccines for enabling nations to become medicinally independent, and to overcome disruptions in global supply chains. Hence, countries in MEA region are increasing focus on localization of pharmaceutical sector post COVID-19 to achieve self-reliance and decrease high dependence on imports of pharmaceutical products.
The COVID-19 pandemic has bolstered the necessity of investment in resilient and self-reliant healthcare infrastructure, which has created a demand for our expertise in integrating advanced manufacturing, reliable supply chains and affordable health care for various developing nations.
Thus, our service portfolio of consolidating robust pharmaceutical and healthcare capabilities has offered targeted support for building infrastructure in growing economies for addressing respiratory, blood renal and oncology disorders.
Our comprehensive solutions encompasses the entire project lifecycle of our customers and address the three key elements in pharmaceuticals, biotech and healthcare facilities, namely, bio clean air, clean water, and process. In addition to offering targeted solutions across the value chain.
we also have an established track record in executing pharmaceutical projects across a diverse range of dosage forms, encompassing, liquids, solids, and semisolids.
Our turnkey engineering solutions involve an extensive range of services, viz., comprehensive market analysis that combines geographic and demographic insights to understand the current and future competitive environment, disease profiling for aligning solutions to the specific needs of the target market, designing and detailed engineering of equipment tailored to the manufacturing process and the applicable quality standards, leveraging the best technologies to enhance the efficiency, reliability, and sustainability of the projects and execution and commissioning strategy.
OBJECTS OF ISSUE
1. Funding working capital requirements of our Company.
2. Pursuing inorganic growth initiatives through acquisitions.
3. General Corporate Purposes.
Qualitative Factors
- A key turnkey engineering solution provider offering integrated engineering solutions with comprehensive service offerings.
- Track record of executing projects across all dosage forms.
- In-house software technology capabilities.
- Asset-light and integrated business model.
- Diversified Order Book across geographies, clients, and business verticals.
- Project execution across diverse and challenging geographies.
- Efficient lead funnelling leading to higher mandate conversion.
- Experienced Leadership Team with Fabtech Group parentage.
Fabtech Technologies Comparison of Accounting Ratios with Peer Group Companies .
- ION Exchange (India) Limited.
- VA Tech Wabag Limited.
